OPX Biotechnologies
In my third part of my 3 part Q & A with Charles Eggert, CEO of OPX Biotechnologies, he discusses the current state of affairs in the biofuels industry and policy.
ROBERT GLUCK: How do you view the current state of affairs of the American biofuels industry? Biochemicals industry?
In the second part of my Q & A with OPX Biotechnologies' CEO Charles Eggert, he discusses the use of carbon dioxide and hydrogen feedstock, plans for future projects, and converting microbial fuel into jet fuel.





